These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 11144992)

  • 1. Single-dose pharmacokinetics of sotalol in a pediatric population with supraventricular and/or ventricular tachyarrhythmia.
    Saul JP; Schaffer MS; Karpawich PP; Erickson CC; Epstein MR; Melikian AP; Shi J; Karara AH; Cai B; Hinderling PH
    J Clin Pharmacol; 2001 Jan; 41(1):35-43. PubMed ID: 11144992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population pharmacokinetics and pharmacodynamics of sotalol in pediatric patients with supraventricular or ventricular tachyarrhythmia.
    Shi J; Ludden TM; Melikian AP; Gastonguay MR; Hinderling PH
    J Pharmacokinet Pharmacodyn; 2001 Dec; 28(6):555-75. PubMed ID: 11999292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and pharmacodynamics of sotalol in a pediatric population with supraventricular and ventricular tachyarrhythmia.
    Saul JP; Ross B; Schaffer MS; Beerman L; Melikian AP; Shi J; Williams J; Barbey JT; Jin J; Hinderling PH;
    Clin Pharmacol Ther; 2001 Mar; 69(3):145-57. PubMed ID: 11240979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New antiarrhythmic drug in pediatric use: sotalol.
    Pfammatter JP; Paul T
    Pediatr Cardiol; 1997; 18(1):28-34. PubMed ID: 8960489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sotalol: a new class III antiarrhythmic agent.
    Zanetti LA
    Clin Pharm; 1993 Dec; 12(12):883-91. PubMed ID: 8137605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a safe and effective pediatric dosing regimen for sotalol based on population pharmacokinetics and pharmacodynamics in children with supraventricular tachycardia.
    Läer S; Elshoff JP; Meibohm B; Weil J; Mir TS; Zhang W; Hulpke-Wette M
    J Am Coll Cardiol; 2005 Oct; 46(7):1322-30. PubMed ID: 16198851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adverse event rate during inpatient sotalol initiation for the management of supraventricular and ventricular tachycardia in the pediatric and young adult population.
    Chandler SF; Chu E; Whitehill RD; Bevilacqua LM; Bezzerides VJ; DeWitt ES; Alexander ME; Abrams DJ; Triedman JK; Walsh EP; Mah DY
    Heart Rhythm; 2020 Jun; 17(6):984-990. PubMed ID: 32014568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Results of oral sotalol therapy in children with supraventricular and ventricular arrhythmias].
    Paul T; Lehmann C; Pfammatter JP; Kallfelz HC
    Z Kardiol; 1994 Dec; 83(12):891-7. PubMed ID: 7531374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sotalol: a breakthrough antiarrhythmic?
    Nappi JM; McCollam PL
    Ann Pharmacother; 1993 Nov; 27(11):1359-68. PubMed ID: 8286812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are women more susceptible than men to drug-induced QT prolongation? Concentration-QTc modelling in a phase 1 study with oral rac-sotalol.
    Darpo B; Karnad DR; Badilini F; Florian J; Garnett CE; Kothari S; Panicker GK; Sarapa N
    Br J Clin Pharmacol; 2014 Mar; 77(3):522-31. PubMed ID: 23819796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sotalol in neonates for arrhythmias: Dosing, safety, and efficacy.
    Kiskaddon AL; Decker J
    J Cardiovasc Electrophysiol; 2023 Jun; 34(6):1459-1463. PubMed ID: 37210614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pediatric Dosing of Intravenous Sotalol Based on Body Surface Area in Patients with Arrhythmia.
    Li X; Zhang Y; Liu H; Jiang H; Ge H; Zhang Y
    Pediatr Cardiol; 2017 Oct; 38(7):1450-1455. PubMed ID: 28755092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and proarrhythmia of oral sotalol in pediatric patients.
    Pfammatter JP; Paul T; Lehmann C; Kallfelz HC
    J Am Coll Cardiol; 1995 Oct; 26(4):1002-7. PubMed ID: 7560592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of Intravenous Sotalol for Treatment of Incessant Tachyarrhythmias in Children.
    Li X; Zhang Y; Liu H; Jiang H; Ge H; Zhang Y
    Am J Cardiol; 2017 May; 119(9):1366-1370. PubMed ID: 28283175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and proarrhythmia with the use of d,l-sotalol for sustained ventricular tachyarrhythmias.
    Kühlkamp V; Mermi J; Mewis C; Seipel L
    J Cardiovasc Pharmacol; 1997 Mar; 29(3):373-81. PubMed ID: 9125676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-dose sotalol in pediatric arrhythmia therapy.
    Rokicki W; Dukalska M
    Pediatr Cardiol; 1999; 20(2):172-3. PubMed ID: 9986903
    [No Abstract]   [Full Text] [Related]  

  • 17. Sotalol for refractory arrhythmias in pediatric and young adult patients: initial efficacy and long-term outcome.
    Tanel RE; Walsh EP; Lulu JA; Saul JP
    Am Heart J; 1995 Oct; 130(4):791-7. PubMed ID: 7572588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of sustained ventricular tachyarrhythmias: a comparison of d,l-sotalol with no antiarrhythmic drug treatment.
    Kühlkamp V; Mewis C; Mermi J; Bosch RF; Seipel L
    J Am Coll Cardiol; 1999 Jan; 33(1):46-52. PubMed ID: 9935007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of landiolol hydrochloride, a new ultra-short-acting beta-blocker, in patients with cardiac arrhythmias.
    Atarashi H; Kuruma A; Yashima M; Saitoh H; Ino T; Endoh Y; Hayakawa H
    Clin Pharmacol Ther; 2000 Aug; 68(2):143-50. PubMed ID: 10976545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Practical considerations in the use of sotalol for ventricular tachycardia and ventricular fibrillation.
    Campbell RW; Furniss SS
    Am J Cardiol; 1993 Aug; 72(4):80A-85A. PubMed ID: 8346732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.